EQL Pharma AB (EQL.ST) — Stock Score Summary

EQL Pharma AB (EQL.ST) has a MoatMap StockRank of 9/100 based on Quality (37/100), Value (25/100), and Momentum (28/100) factor scores. The current signal is STRONG SELL. Swedish specialty pharma company focusing on niche generics. While it has decent growth, it lacks the massive scale, regulatory moat, and pricing power of a true CDMO gatekeeper.

EQL Pharma AB specializes in identifying, developing, and distributing niche generic pharmaceuticals that lack significant competition in the Nordic region. The company employs an asset-light, outsourced manufacturing model to maintain low overhead and rapid time-to-market. EQL Pharma's competitive moat lies in its regulatory expertise and focus on low-volume, high-barrier generic drugs overlooked by larger pharmaceutical multinationals.

Key Financial Metrics

Price$2.72
Market Cap$79M
P/E (TTM)60.24
P/E (Forward)8.08
Price/Book2.80
Return on Equity-1.1%
Return on Invested Capital7.6%
Gross Margin55.2%
Operating Margin-16.7%
Revenue Growth21.3%
Free Cash Flow$-259K

EQL Pharma AB operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Sweden).

Frequently Asked Questions

What is EQL Pharma AB’s (EQL.ST) StockRank?
MoatMap’s StockRank for EQL Pharma AB (EQL.ST) is 9/100, with a Strong Sell signal. It is a composite of Quality (37), Value (25), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does EQL Pharma AB have an economic moat?
EQL Pharma AB (EQL.ST) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is EQL Pharma AB a buy, hold, or sell?
MoatMap’s current signal for EQL Pharma AB (EQL.ST) is Strong Sell, based on a StockRank of 9/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is EQL Pharma AB in?
EQL Pharma AB (EQL.ST) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Sweden).
Browse all ranked stocksEQL.ST deep dive reportAI ChampionsHow we score stocksSense-check another stock